Liu Yi-Hua, Ye Yang, Zheng Jia-Bin, Wang Xue-Qian, Zhang Ying, Lin Hong-Sheng
Graduate School of Beijing University of Chinese Medicine Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Medicine (Baltimore). 2017 Apr;96(17):e6644. doi: 10.1097/MD.0000000000006644.
Cancer patients undergoing surgical procedure often suffer from bowel dysfunction and postoperative ileus (POI). Cancer management for early recovery of bowel function is still a challenging topic. Acupuncture has been commonly used in a variety of gastrointestinal diseases. The aim of this study is to evaluate the effects of acupuncture therapy to reduce the duration of POI and enhance bowel function in cancer patients.
We will systematically screen all randomized controlled trials (RCTs) published through electronically and hand searching. The following search engines including Medline, EMBASE, Cochrane CENTRAL, the Cumulative Index to Nursing and Allied Health Literature, Allied and Complementary Medicine Database, the Chinese Biomedical Literature Database, the China National Knowledge Infrastructure, VIP Information, Wanfang Data, one Japanese database (Japan Science and Technology Information Aggregator, Electronic) and 2 Korean Medical Databases (Korean Studies Information, and Data Base Periodical Information Academic) will be retrieved. Supplementary sources will be searched including gray literature, conference proceedings, and potential identified publications. Two reviewers will independently conduct the trial inclusion, data extraction and assess the quality of studies. The time to first passing flatus and time to first bowel motion will be assessed as the primary outcomes. Adverse effects, time to first bowel sound, visual analog scale (VAS) pain score, hospital stay, and postoperative analgesic requirement will be measured as secondary outcomes. Methodological quality will be evaluated according to the Cochrane risk of bias. Details of interventions will be assessed by the Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA) checklist. All analyses will be applied by RevMan (version 5.3) and StataSE (version 12).
This systematic review will provide up-to-date information on acupuncture therapy for early recovery of bowel function in cancer patients. This review does not require ethical approval and will be reported in a peer-reviewed journal and presented at a relevant conference.
PROSPERO CRD42016049633.
接受外科手术的癌症患者常遭受肠道功能障碍和术后肠梗阻(POI)之苦。促进癌症患者肠道功能早期恢复的治疗方法仍是一个具有挑战性的课题。针灸已广泛应用于多种胃肠道疾病。本研究旨在评估针刺疗法对缩短癌症患者POI持续时间及促进肠道功能恢复的效果。
我们将通过电子检索和手工检索系统筛选所有已发表的随机对照试验(RCT)。检索以下搜索引擎,包括医学文献数据库(Medline)、荷兰医学文摘数据库(EMBASE)、考克兰系统评价数据库(Cochrane CENTRAL)、护理学与健康相关文献累积索引数据库(Cumulative Index to Nursing and Allied Health Literature)、补充与替代医学数据库(Allied and Complementary Medicine Database)、中国生物医学文献数据库、中国知网、维普资讯、万方数据、一个日本数据库(日本科学技术信息集成平台,电子版)以及两个韩国医学数据库(韩国研究信息数据库和韩国期刊信息学术数据库)。还将检索补充资源,包括灰色文献、会议论文集及潜在的已识别出版物。两名评价员将独立进行试验纳入、数据提取并评估研究质量。首次排气时间和首次排便时间将作为主要结局指标进行评估。不良反应、首次肠鸣音出现时间、视觉模拟评分法(VAS)疼痛评分、住院时间及术后镇痛需求将作为次要结局指标进行测量。方法学质量将根据考克兰偏倚风险进行评估。干预措施的详细信息将通过针刺临床试验报告规范(STRICTA)清单进行评估。所有分析将采用RevMan(版本5.3)和StataSE(版本12)软件进行。
本系统评价将提供关于针刺疗法促进癌症患者肠道功能早期恢复的最新信息。本评价无需伦理批准,并将在同行评审期刊上发表,并在相关会议上展示。
PROSPERO CRD42016049633。